AVANSCURE LIFESCIENCES PVT. LTD.
Dexlansoprazole Pellets

Dexlansoprazole Pellets

Send Inquiry

Avanscure Lifesciences Pvt. Ltd., global Manufacturer of  30%,60% offers for your requirements of RND / Development quantities or commercials, based on status of the product.

Dex Lansoprazole is a proton pump inhibitor that is marketed by Takeda Pharmaceuticals. Chemically, it is an enantiomer of lansoprazole.

The compound was launched in the US for use in the treatment and maintenance of patients with erosive oesophagitis and non-erosive gastro-oesophageal reflux disease (GERD or GORD).

 

Making ready to fill pellets / compressible granules.

Making process suitability for your products.

Deciding the right kind of technology / equipment’s for the products.

Process Validation Stability.

Technology transfer of products with complete line of equipment’s.

 

Dex Lansoprazole
Systematic (IUPAC) Name

Dex Lansoprazole
Identifiers

Dex Lansoprazole
Chemical data

(R)-(+)2-([3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl)-1H-benzo[d]imidazole

CAS number

: 138530-94-6

Formula

: C16H14F3N3O2S

Mol. mass

: 369.363 g/mol